Related Experiment Video
Updated: Apr 11, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Hospitalization Type and Subsequent Severe Sepsis
Hallie C Prescott1,2, Robert P Dickson1, Mary A M Rogers1,2
11 Department of Internal Medicine and.
Rationale:
Hospitalization is associated with microbiome perturbation (dysbiosis), and this perturbation is more severe in patients treated with antimicrobials.
Objectives:
To evaluate whether hospitalizations known to be associated with periods of microbiome perturbation are associated with increased risk of severe sepsis after hospital discharge.
Methods:
We studied participants in the U.S. Health and Retirement Study with linked Medicare claims (1998-2010). We measured whether three hospitalization types associated with increasing severity of probable dysbiosis (non-infection-related hospitalization, infection-related hospitalization, and hospitalization with Clostridium difficile infection [CDI]) were associated with increasing risk for severe sepsis in the 90 days after hospital discharge. We used two study designs: the first was a longitudinal design with between-person comparisons and the second was a self-controlled case series design using within-person comparison.
Measurements And Main Results:
We identified 43,095 hospitalizations among 10,996 Health and Retirement Study-Medicare participants. In the 90 days following non-infection-related hospitalization, infection-related hospitalization, and hospitalization with CDI, adjusted probabilities of subsequent admission for severe sepsis were 4.1% (95% confidence interval [CI], 3.8-4.4%), 7.1% (95% CI, 6.6-7.6%), and 10.7% (95% CI, 7.7-13.8%), respectively. The incidence rate ratio (IRR) of severe sepsis was 3.3-fold greater during the 90 days after hospitalizations than during other observation periods. The IRR was 30% greater after an infection-related hospitalization versus a non-infection-related hospitalization. The IRR was 70% greater after a hospitalization with CDI than an infection-related hospitalization without CDI.
Conclusions:
There is a strong dose-response relationship between events known to result in dysbiosis and subsequent severe sepsis hospitalization that is not present for rehospitalization for nonsepsis diagnoses.
Insights
Hospitalization disrupts the gut microbiome, increasing severe sepsis risk. This risk escalates with hospitalization type, from general stays to Clostridium difficile infection (CDI), highlighting a dose-response relationship.
Area of Science:
- Microbiome research
- Infectious disease epidemiology
- Healthcare-associated infections
Background:
- Hospitalization commonly causes microbiome disruption (dysbiosis).
- Antimicrobial use exacerbates dysbiosis during hospital stays.
Purpose of the Study:
- To investigate the association between hospitalization-induced dysbiosis and severe sepsis risk post-discharge.
- To determine if different types of hospitalizations correlate with varying severe sepsis risks.
Main Methods:
- Analysis of U.S. Health and Retirement Study participants with linked Medicare claims (1998-2010).
- Comparison of severe sepsis risk within 90 days following non-infection-related hospitalization, infection-related hospitalization, and Clostridium difficile infection (CDI) hospitalization.
- Utilized longitudinal and self-controlled case series study designs.
Main Results:
- Severe sepsis risk increased with hospitalization severity: 4.1% after non-infection-related, 7.1% after infection-related, and 10.7% after CDI hospitalizations.
- The incidence rate ratio (IRR) for severe sepsis was 3.3-fold higher post-hospitalization compared to other periods.
- IRR was 30% higher after infection-related vs. non-infection-related hospitalizations, and 70% higher after CDI vs. infection-related hospitalizations.
Conclusions:
- A significant dose-response relationship exists between dysbiosis-inducing events and subsequent severe sepsis hospitalization.
- This relationship was specific to sepsis diagnoses and not observed for other rehospitalizations.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia III: Complications and Assessment
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

